Ironwood Pharmaceuticals, Inc. (IRWD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 546.66M |
| Enterprise Value | 929.01M |
| P/E Ratio | 5.39 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.81 |
| Price/Book Ratio | -4.39 |
| Enterprise/Revenue | 2.63 |
| Enterprise/EBITDA | 4.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.33 |
| Operating Margin | 0.61 |
| Return On Assets | 0.46 |
| Return On Equity | -0.57 |
| Revenue | 296.15M |
| Revenue/Share | 2.35 |
| Gross Profit | 296.15M |
| EBITDA | 104.65M |
| Net Income | 24.02M |
| Diluted EPS | 0.15 |
| Total Cash | 79.13M |
| Total Cash/Share | 0.48 |
| Total Debt | 396.87M |
| Total Debt/Equity | -2.45 |
| Current Ratio | 6.06 |
| Book Value Per Share | -0.98 |
| 52-Week Change | 263.56 |
| 52-Week High | 5.78 |
| 52-Week Low | 1.01 |
| Moving Average 50 Days | 4.05 |
| Moving Average 200 Days | 3.84 |
| Average Volume | 2.31M |
| Shares Outstanding | 164.61M |
| % Held by Institutions | 100.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 597:500 |
| Last Split Date | April 02, 2019 |